Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Basking Ridge, New Jersey
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,002+ filings
- On EDGAR
- CIK 320017
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 73
News 8 of 215
Prospectuses and Registrations 8 of 85
- S-8 Registration statement for an employee plan Jan 8, 2026
- 424B5 Prospectus supplement for an offering Aug 21, 2024
- S-8 Registration statement for an employee plan Jul 15, 2024
- S-3 Shelf registration statement May 1, 2024
- S-8 Registration statement for an employee plan Jul 13, 2023
- S-8 Registration statement for an employee plan Oct 17, 2022
- 424B5 Prospectus supplement for an offering Sep 26, 2022
- 424B3 Prospectus supplement for an offering Jul 29, 2022
Proxies 8 of 40
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material May 1, 2023
- DEF 14A Proxy statement for a shareholder vote May 1, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2021
- DEFA14A Extra proxy material Apr 28, 2021
Ownership 8 of 490
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Jan 13, 2026
Other 8 of 99
Everything here comes from Lisata Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.